P55017 (S12A3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 123.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Solute carrier family 12 member 3 Alternative name(s): Na-Cl cotransporter Short name=NCC Na-Cl symporter Thiazide-sensitive sodium-chloride cotransporter | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1021 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Key mediator of sodium and chloride reabsorption in this nephron segment, accounting for a significant fraction of renal sodium reabsorption. Ref.1 |
| Enzyme regulation | Activated by WNK3. Ref.5 |
| Subunit structure | Interacts with KLHL3. Ref.7 |
| Subcellular location | |
| Tissue specificity | Predominant in kidney. |
| Post-translational modification | Ubiquitinated; ubiquitination is essential for regulation of endocytosis By similarity. May be ubiquitinated by the BCR(KLHL3) complex. Ref.7 |
| Involvement in disease | Gitelman syndrome (GS) [MIM:263800]: An autosomal recessive disorder characterized by hypokalemic alkalosis in combination with hypomagnesemia, low urinary calcium, and increased renin activity associated with normal blood pressure. Patients are often asymptomatic or present transient periods of muscular weakness and tetany, usually accompanied by abdominal pain, vomiting and fever. The phenotype is highly heterogeneous in terms of age at onset and severity. Cardinal features such as hypocalciuria and hypomagnesemia might also change during the life cycle of a given patient. It has overlapping features with Bartter syndrome. |
| Miscellaneous | Target of thiazide diuretics used in the treatment of high blood pressure (Ref.1). |
| Sequence similarities | Belongs to the SLC12A transporter family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Ion transport Sodium transport Symport Transport |
| Cellular component | Cell membrane Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Disease mutation |
| Domain | Transmembrane Transmembrane helix |
| Ligand | Sodium |
| PTM | Glycoprotein Ubl conjugation |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | sodium ion transmembrane transport Inferred from sequence or structural similarity. Source: BHF-UCL |
| Cellular_component | apical plasma membrane Inferred from sequence or structural similarity. Source: UniProtKB cytosolInferred from electronic annotation. Source: Compara integral to plasma membraneTraceable author statement PubMed 8670281. Source: ProtInc |
| Molecular_function | sodium:chloride symporter activity Traceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P55017-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P55017-2) The sequence of this isoform differs from the canonical sequence as follows: 807-807: V → GARPSVSGAL | ||||||
| Isoform 3 (identifier: P55017-3) The sequence of this isoform differs from the canonical sequence as follows: 95-95: Missing. 807-807: V → GARPSVSGAL | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1021 | 1021 | Solute carrier family 12 member 3 | PRO_0000178026 | |||||
Regions | |||||||||
| Topological domain | 1 – 135 | 135 | Cytoplasmic Potential | ||||||
| Transmembrane | 136 – 156 | 21 | Helical; Potential | ||||||
| Transmembrane | 159 – 179 | 21 | Helical; Potential | ||||||
| Topological domain | 180 – 218 | 39 | Cytoplasmic Potential | ||||||
| Transmembrane | 219 – 239 | 21 | Helical; Potential | ||||||
| Transmembrane | 262 – 282 | 21 | Helical; Potential | ||||||
| Topological domain | 283 – 286 | 4 | Cytoplasmic Potential | ||||||
| Transmembrane | 287 – 307 | 21 | Helical; Potential | ||||||
| Transmembrane | 340 – 360 | 21 | Helical; Potential | ||||||
| Topological domain | 361 – 377 | 17 | Cytoplasmic Potential | ||||||
| Transmembrane | 378 – 398 | 21 | Helical; Potential | ||||||
| Transmembrane | 453 – 473 | 21 | Helical; Potential | ||||||
| Topological domain | 474 – 511 | 38 | Cytoplasmic Potential | ||||||
| Transmembrane | 512 – 532 | 21 | Helical; Potential | ||||||
| Transmembrane | 535 – 555 | 21 | Helical; Potential | ||||||
| Topological domain | 556 – 577 | 22 | Cytoplasmic Potential | ||||||
| Transmembrane | 578 – 598 | 21 | Helical; Potential | ||||||
| Transmembrane | 661 – 681 | 21 | Helical; Potential | ||||||
| Topological domain | 682 – 1021 | 340 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 406 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 426 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 95 | 1 | Missing in isoform 3. | VSP_040100 | |||||
| Alternative sequence | 807 | 1 | V → GARPSVSGAL in isoform 2 and isoform 3. | VSP_036318 | |||||
| Natural variant | 60 | 1 | T → M in GS. Ref.16 | VAR_039475 | |||||
| Natural variant | 62 | 1 | D → N in GS. Ref.6 | VAR_039476 | |||||
| Natural variant | 68 | 1 | E → K in GS. Ref.19 | VAR_039477 | |||||
| Natural variant | 69 | 1 | H → N in GS. Ref.19 | VAR_039478 | |||||
| Natural variant | 90 | 1 | H → Y in GS. Ref.17 | VAR_039479 | |||||
| Natural variant | 145 | 1 | R → H in GS. Ref.19 | VAR_039480 | |||||
| Natural variant | 153 | 1 | V → M in GS. Ref.19 | VAR_039481 | |||||
| Natural variant | 154 | 1 | I → F in GS. Ref.12 | VAR_039482 | |||||
| Natural variant | 158 | 1 | R → Q in GS. Ref.15 | VAR_039483 | |||||
| Natural variant | 163 | 1 | T → M in GS. Ref.15 | VAR_039484 | |||||
| Natural variant | 172 | 1 | W → R in GS. Ref.15 | VAR_039485 | |||||
| Natural variant | 178 | 1 | S → L in GS. Ref.12 | VAR_039486 | |||||
| Natural variant | 180 | 1 | T → K in GS. Ref.11 | VAR_039487 | |||||
| Natural variant | 186 | 1 | G → D in GS. Ref.6 | VAR_039488 | |||||
| Natural variant | 209 | 1 | R → Q in GS. Ref.12 Corresponds to variant rs28936388 [ dbSNP | Ensembl ]. | VAR_039489 | |||||
| Natural variant | 209 | 1 | R → W in GS. Ref.1 Ref.6 Ref.9 Ref.15 Corresponds to variant rs28936388 [ dbSNP | Ensembl ]. | VAR_007113 | |||||
| Natural variant | 215 | 1 | L → P in GS. Ref.9 | VAR_039490 | |||||
| Natural variant | 226 | 1 | A → T in GS. Ref.9 | VAR_039491 | |||||
| Natural variant | 230 | 1 | G → D in GS. Ref.19 | VAR_039492 | |||||
| Natural variant | 261 | 1 | R → H in GS. Ref.9 | VAR_039493 | |||||
| Natural variant | 264 | 1 | A → G. Ref.1 Ref.2 Ref.3 Ref.13 Ref.21 Corresponds to variant rs1529927 [ dbSNP | Ensembl ]. | VAR_039494 | |||||
| Natural variant | 283 | 1 | S → Y in GS. Ref.17 | VAR_039495 | |||||
| Natural variant | 284 | 1 | K → R in GS. Ref.12 | VAR_039496 | |||||
| Natural variant | 304 | 1 | T → P in GS. Ref.10 | VAR_039497 | |||||
| Natural variant | 313 | 1 | A → V in GS. Ref.12 | VAR_039498 | |||||
| Natural variant | 316 | 1 | G → V in GS. Ref.15 | VAR_039499 | |||||
| Natural variant | 321 | 1 | R → W in GS. Ref.12 | VAR_039500 | |||||
| Natural variant | 334 | 1 | R → W in GS. Ref.12 | VAR_039501 | |||||
| Natural variant | 342 | 1 | G → A in GS. Ref.19 | VAR_039502 | |||||
| Natural variant | 349 | 1 | P → L in GS. Ref.1 Ref.6 | VAR_007114 | |||||
| Natural variant | 374 | 1 | G → V in GS. Ref.15 | VAR_039503 | |||||
| Natural variant | 399 | 1 | R → C in GS. Ref.12 | VAR_039504 | |||||
| Natural variant | 421 | 1 | C → R in GS. Ref.1 Corresponds to variant rs28936387 [ dbSNP | Ensembl ]. | VAR_007115 | |||||
| Natural variant | 439 | 1 | G → S in GS. Ref.6 Ref.10 | VAR_039505 | |||||
| Natural variant | 463 | 1 | G → E in GS. Ref.15 | VAR_039506 | |||||
| Natural variant | 464 | 1 | A → T in GS. Ref.15 | VAR_039507 | |||||
| Natural variant | 478 | 1 | K → E in GS. Ref.6 | VAR_039508 | |||||
| Natural variant | 486 | 1 | D → N in GS. Ref.1 Ref.6 | VAR_007116 | |||||
| Natural variant | 496 | 1 | G → C in GS. Ref.1 Ref.6 | VAR_007117 | |||||
| Natural variant | 542 | 1 | L → P in GS. Ref.6 | VAR_039509 | |||||
| Natural variant | 555 | 1 | S → L in GS. Ref.12 | VAR_039510 | |||||
| Natural variant | 560 | 1 | P → H in GS. Ref.9 | VAR_039511 | |||||
| Natural variant | 561 | 1 | Missing in GS. Ref.1 | VAR_007118 | |||||
| Natural variant | 569 | 1 | A → E in GS. Ref.11 | VAR_039512 | |||||
| Natural variant | 569 | 1 | A → V in GS. Ref.16 | VAR_039513 | |||||
| Natural variant | 578 | 1 | V → M in GS. Ref.11 | VAR_039514 | |||||
| Natural variant | 588 | 1 | A → V in GS. Ref.1 Ref.6 | VAR_007119 | |||||
| Natural variant | 613 | 1 | G → S in GS. Ref.9 | VAR_039515 | |||||
| Natural variant | 615 | 1 | S → L in GS. Ref.12 Ref.15 | VAR_039516 | |||||
| Natural variant | 615 | 1 | S → W in GS. Ref.15 | VAR_039517 | |||||
| Natural variant | 623 | 1 | L → P in GS. Ref.8 Ref.14 | VAR_039518 | |||||
| Natural variant | 630 | 1 | G → V in GS. Ref.1 Corresponds to variant rs28936389 [ dbSNP | Ensembl ]. | VAR_007120 | |||||
| Natural variant | 642 | 1 | R → C in GS. Ref.11 Ref.16 | VAR_039519 | |||||
| Natural variant | 642 | 1 | R → G in GS. Ref.12 Ref.15 | VAR_039520 | |||||
| Natural variant | 642 | 1 | R → H in GS. Ref.9 Ref.15 | VAR_039521 | |||||
| Natural variant | 643 | 1 | P → L in GS. Ref.12 Ref.13 | VAR_039522 | |||||
| Natural variant | 649 | 1 | T → R in GS. Ref.9 | VAR_039523 | |||||
| Natural variant | 655 | 1 | R → C in GS. Ref.9 | VAR_039524 | |||||
| Natural variant | 655 | 1 | R → H in GS. Ref.1 | VAR_007121 | |||||
| Natural variant | 655 | 1 | R → L in GS. Ref.1 | VAR_007122 | |||||
| Natural variant | 672 | 1 | M → I in GS. Ref.18 | VAR_039525 | |||||
| Natural variant | 677 | 1 | V → L in GS. Ref.19 | VAR_039526 | |||||
| Natural variant | 677 | 1 | V → M in GS. Ref.15 | VAR_039527 | |||||
| Natural variant | 728 | 1 | A → T. Ref.1 Ref.21 Corresponds to variant rs36049418 [ dbSNP | Ensembl ]. | VAR_007123 | |||||
| Natural variant | 729 | 1 | G → V in GS. Ref.12 | VAR_039528 | |||||
| Natural variant | 731 | 1 | G → R in GS. Ref.6 Ref.10 | VAR_039529 | |||||
| Natural variant | 738 | 1 | L → R in GS. Ref.9 | VAR_039530 | |||||
| Natural variant | 741 | 1 | G → R in GS. Ref.1 Ref.9 Ref.10 | VAR_007124 | |||||
| Natural variant | 849 | 1 | L → H in GS. Ref.11 Ref.16 Ref.20 | VAR_039531 | |||||
| Natural variant | 850 | 1 | L → P in GS. Ref.1 Ref.9 | VAR_007125 | |||||
| Natural variant | 852 | 1 | R → C in GS. Ref.9 Ref.15 | VAR_039532 | |||||
| Natural variant | 852 | 1 | R → H in GS. Ref.20 | VAR_039533 | |||||
| Natural variant | 852 | 1 | R → S in GS. Ref.15 | VAR_039534 | |||||
| Natural variant | 854 | 1 | R → K. Corresponds to variant rs8060046 [ dbSNP | Ensembl ]. | VAR_060106 | |||||
| Natural variant | 867 | 1 | G → S in GS. Ref.19 | VAR_039535 | |||||
| Natural variant | 871 | 1 | R → H in GS. Ref.17 | VAR_039536 | |||||
| Natural variant | 904 | 1 | R → Q. Ref.9 Ref.10 Ref.15 Ref.21 Corresponds to variant rs11643718 [ dbSNP | Ensembl ]. | VAR_039537 | |||||
| Natural variant | 919 | 1 | R → C Increases sodium transport. Ref.9 Ref.21 Corresponds to variant rs12708965 [ dbSNP | Ensembl ]. | VAR_039538 | |||||
| Natural variant | 955 | 1 | R → Q in GS. Ref.1 | VAR_007126 | |||||
| Natural variant | 958 | 1 | R → G in GS. Ref.15 | VAR_039539 | |||||
| Natural variant | 985 | 1 | C → Y in GS. Ref.15 | VAR_039540 | |||||
Experimental info | |||||||||
| Sequence conflict | 459 – 460 | 2 | AG → VV in CAA62613. Ref.2 | ||||||
| Sequence conflict | 539 | 1 | S → P in AK315298. Ref.3 | ||||||
| Sequence conflict | 766 | 1 | D → E in AAC50355. Ref.1 | ||||||
| Sequence conflict | 778 | 1 | Missing in AK315298. Ref.3 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter." Simon D.B., Nelson-Williams C., Bia M.J., Ellison D., Karet F.E., Molina A.M., Vaara I., Iwata F., Cushner H.M., Koolen M., Gainza F.J., Gitelman H.J., Lifton R.P. Nat. Genet. 12:24-30(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), VARIANTS GS TRP-209; GLY-264; LEU-349; ARG-421; ASN-486; CYS-496; SER-561 DEL; VAL-588; VAL-630; HIS-655; LEU-655; ARG-741; PRO-850 AND GLN-955, VARIANT THR-728, FUNCTION. |
| [2] | "Molecular cloning, expression pattern, and chromosomal localization of the human Na-Cl thiazide-sensitive cotransporter (SLC12A3)." Mastroianni N., de Fusco M., Zollo M., Arrigo G., Zuffardi O., Bettinelli A., Ballabio A., Casari G. Genomics 35:486-493(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT GLY-264. Tissue: Kidney. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), VARIANT GLY-264. |
| [4] | "The sequence and analysis of duplication-rich human chromosome 16." Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J. Pennacchio L.A.Nature 432:988-994(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Similar Effects of all WNK3 Variants upon SLC12 Cotransporters." Cruz-Rangel S., Melo Z., Vazquez N., Meade P., Bobadilla N.A., Pasantes-Morales H., Gamba G., Mercado A. Am. J. Physiol. 301:C601-C608(2011) [PubMed] [Europe PMC] [Abstract] Cited for: ENZYME REGULATION. |
| [6] | "Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome." Mastroianni N., Bettinelli A., Bianchetti M., Colussi G., De Fusco M., Sereni F., Ballabio A., Casari G. Am. J. Hum. Genet. 59:1019-1026(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS ASN-62; ASP-186; TRP-209; LEU-349; SER-439; GLU-478; ASN-486; CYS-496; PRO-542; VAL-588 AND ARG-731. |
| [7] | "KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron." Louis-Dit-Picard H., Barc J., Trujillano D., Miserey-Lenkei S., Bouatia-Naji N., Pylypenko O., Beaurain G., Bonnefond A., Sand O., Simian C., Vidal-Petiot E., Soukaseum C., Mandet C., Broux F., Chabre O., Delahousse M., Esnault V., Fiquet B. Jeunemaitre X.Nat. Genet. 0:0-0(2012) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH KLHL3, UBIQUITINATION. |
| [8] | "Association of a mutation in thiazide-sensitive Na-Cl cotransporter with familial Gitelman's syndrome." Takeuchi K., Kure S., Kato T., Taniyama Y., Takahashi N., Ikeda Y., Abe T., Narisawa K., Muramatsu Y., Abe K. J. Clin. Endocrinol. Metab. 81:4496-4499(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GS PRO-623. |
| [9] | "Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain." Lemmink H.H., Knoers N.V.A.M., Karolyi L., van Dijk H., Niaudet P., Antignac C., Guay-Woodford L.M., Goodyer P.R., Carel J.-C., Hermes A., Seyberth H.W., Monnens L.A.H., van den Heuvel L.P.W.J. Kidney Int. 54:720-730(1998) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS TRP-209; PRO-215; THR-226; HIS-261; HIS-560; SER-613; HIS-642; ARG-649; CYS-655; ARG-738; ARG-741; PRO-850 AND CYS-852, VARIANTS GLN-904 AND CYS-919. |
| [10] | "Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension." Melander O., Orho-Melander M., Bengtsson K., Lindblad U., Rastam L., Groop L., Hulthen U.L. Hypertension 36:389-394(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS PRO-304; SER-439; ARG-731 AND ARG-741, VARIANT GLN-904. |
| [11] | "Novel mutations in thiazide-sensitive Na-Cl cotransporter gene of patients with Gitelman's syndrome." Monkawa T., Kurihara I., Kobayashi K., Hayashi M., Saruta T. J. Am. Soc. Nephrol. 11:65-70(2000) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS LYS-180; GLU-569; MET-578; CYS-642 AND HIS-849. |
| [12] | "Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life." Cruz D.N., Shaer A.J., Bia M.J., Lifton R.P., Simon D.B. Kidney Int. 59:710-717(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS PHE-154; LEU-178; GLN-209; ARG-284; VAL-313; TRP-321; TRP-334; CYS-399; LEU-555; LEU-615; GLY-642; LEU-643 AND VAL-729. |
| [13] | "Severe hypomagnesaemia-induced hypocalcaemia in a patient with Gitelman's syndrome." Pantanetti P., Arnaldi G., Balercia G., Mantero F., Giacchetti G. Clin. Endocrinol. (Oxf.) 56:413-418(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GS LEU-643, VARIANT GLY-264. |
| [14] | "Two novel mutations of thiazide-sensitive Na-Cl cotrans porter (TSC) gene in two sporadic Japanese patients with Gitelman syndrome." Tajima T., Kobayashi Y., Abe S., Takahashi M., Konno M., Nakae J., Okuhara K., Satoh K., Ishikawa T., Imai T., Fujieda K. Endocr. J. 49:91-96(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GS PRO-623. |
| [15] | "Identification of fifteen novel mutations in the SLC12A3 gene encoding the Na-Cl Co-transporter in Italian patients with Gitelman syndrome." Syren M.-L., Tedeschi S., Cesareo L., Bellantuono R., Colussi G., Procaccio M., Ali A., Domenici R., Malberti F., Sprocati M., Sacco M., Miglietti N., Edefonti A., Sereni F., Casari G., Coviello D.A., Bettinelli A. Hum. Mutat. 20:78-78(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS GLN-158; MET-163; ARG-172; TRP-209; VAL-316; VAL-374; GLU-463; THR-464; LEU-615; TRP-615; GLY-642; HIS-642; MET-677; CYS-852; SER-852; GLY-958 AND TYR-985, VARIANT GLN-904. |
| [16] | "Four novel mutations in the thiazide-sensitive Na-Cl co-transporter gene in Japanese patients with Gitelman's syndrome." Maki N., Komatsuda A., Wakui H., Ohtani H., Kigawa A., Aiba N., Hamai K., Motegi M., Yamaguchi A., Imai H., Sawada K. Nephrol. Dial. Transplant. 19:1761-1766(2004) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS MET-60; VAL-569; CYS-642 AND HIS-849. |
| [17] | "Phenotype and genotype analysis in Chinese patients with Gitelman's syndrome." Lin S.-H., Shiang J.-C., Huang C.-C., Yang S.-S., Hsu Y.-J., Cheng C.-J. J. Clin. Endocrinol. Metab. 90:2500-2507(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS TYR-90; TYR-283 AND HIS-871. |
| [18] | "A novel mutation of the thiazide-sensitive sodium chloride cotransporter gene in a Japanese family with Gitelman syndrome." Terui K., Shoji M., Yamashiki J., Hirai Y., Ishiguro A., Tsutaya S., Kageyama K., Yasujima M., Suda T. Clin. Nephrol. 65:57-60(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GS ILE-672. |
| [19] | "Novel mutations in the SLC12A3 gene causing Gitelman's syndrome in Swedes." Fava C., Montagnana M., Rosberg L., Burri P., Joensson A., Wanby P., Wahrenberg H., Hulthen U.L., Aurell M., Guidi G.C., Melander O. DNA Seq. 18:395-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS LYS-68; ASN-69; HIS-145; MET-153; ASP-230; ALA-342; LEU-677 AND SER-867. |
| [20] | "Two novel genotypes of the thiazide-sensitive Na-Cl cotransporter (SLC12A3) gene in patients with Gitelman's syndrome." Aoi N., Nakayama T., Tahira Y., Haketa A., Yabuki M., Sekiyama T., Nakane C., Mano H., Kawachi H., Sato N., Soma M., Matsumoto K. Endocrine 31:149-153(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GS HIS-849 AND HIS-852. |
| [21] | "Molecular variants of the thiazide-sensitive Na+-Cl- cotransporter in hypertensive families." Keszei A.P., Tisler A., Backx P.H., Andrulis I.L., Bull S.B., Logan A.G. J. Hypertens. 25:2074-2081(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS GLY-264; THR-728; GLN-904 AND CYS-919, CHARACTERIZATION OF VARIANT CYS-919. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U44128 mRNA. Translation: AAC50355.1. X91220 mRNA. Translation: CAA62613.1. AK315298 mRNA. No translation available. AC012181 Genomic DNA. No translation available. |
| IPI | IPI00216438. IPI00646907. IPI00893513. |
| PIR | G01202. PC4180. |
| RefSeq | NP_000330.2. NM_000339.2. NP_001119579.1. NM_001126107.1. NP_001119580.1. NM_001126108.1. |
| UniGene | Hs.669115. |
3D structure databases | |
| ProteinModelPortal | P55017. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000262502. |
Protein family/group databases | |
| TCDB | 2.A.30.4.2. cation-chloride cotransporter (CCC) family. |
PTM databases | |
| PhosphoSite | P55017. |
Proteomic databases | |
| PaxDb | P55017. |
| PRIDE | P55017. |
Protocols and materials databases | |
| DNASU | 6559. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000438926; ENSP00000402152; ENSG00000070915. ENST00000563236; ENSP00000456149; ENSG00000070915. ENST00000566786; ENSP00000457552; ENSG00000070915. |
| GeneID | 6559. |
| KEGG | hsa:6559. |
| UCSC | uc002ekd.4. human. uc010ccm.3. human. uc010ccn.3. human. |
Organism-specific databases | |
| CTD | 6559. |
| GeneCards | GC16P056899. |
| HGNC | HGNC:10912. SLC12A3. |
| HPA | CAB022505. HPA028748. |
| MIM | 263800. phenotype. 600968. gene. |
| neXtProt | NX_P55017. |
| Orphanet | 358. Gitelman syndrome. |
| PharmGKB | PA321. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0531. |
| HOGENOM | HOG000062855. |
| HOVERGEN | HBG052851. |
| InParanoid | P55017. |
| KO | K14426. |
| OMA | IGRKGKC. |
| OrthoDB | EOG4CC40K. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| Bgee | P55017. |
| CleanEx | HS_SLC12A3. |
| Genevestigator | P55017. |
| GermOnline | ENSG00000070915. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR004841. AA-permease_dom. IPR013612. AA_permease_N. IPR004842. Na/K/Cl_cotransptS. IPR002948. NaCl_cotranspt. [Graphical view] |
| Pfam | PF00324. AA_permease. 1 hit. PF08403. AA_permease_N. 1 hit. [Graphical view] |
| PRINTS | PR01230. NACLTRNSPORT. |
| TIGRFAMs | TIGR00930. 2a30. 1 hit. |
| ProtoNet | Search... |
Other | |
| ChEMBL | CHEMBL1876. |
| DrugBank | DB00436. Bendroflumethiazide. DB00562. Benzthiazide. DB00880. Chlorothiazide. DB01119. Diazoxide. DB00999. Hydrochlorothiazide. DB00524. Metolazone. DB01324. Polythiazide. DB01325. Quinethazone. |
| GenomeRNAi | 6559. |
| NextBio | 25523. |
| SOURCE | Search... |
Entry information
| Entry name | S12A3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P55017 Secondary accession number(s): A8MSJ2, C9JNN9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
